|
Chronic respiratory diseases (model 1)
|
1.19 (0.86, 1.64)
|
0.299
|
|
Chronic respiratory diseases: sensitivity analyses (model 2)
| | |
|
COPD
|
1.56 (1.06, 2.2)
|
0.024
|
|
Asthma
|
1.03 (0.76, 1.41)
|
0.834
|
|
Interstitial lung disease
|
1.83 (0.74, 4.55)
|
0.193
|
|
Lung cancer
|
1.82 (0.80, 4.14)
|
0.154
|
|
Lung disease d/t external agent
|
3.54 (1.70, 7.38)
|
< 0.001
|
|
Obstructive sleep apnea
|
0.47 (0.06, 3.94)
|
0.486
|
|
Tuberculosis of lung
|
1.65 (0.48, 5.64)
|
0.423
|
|
Age, 10 year increase
|
2.85 (2.40, 3.38)
|
< 0.001
|
|
Income level
| | |
|
Q1 (Lowest)
|
1
| |
|
Q2
|
0.96 (0.59, 1.57)
|
0.882
|
|
Q3
|
1.08 (0.70, 1.65)
|
0.739
|
|
Q4 (Highest)
|
0.89 (0.652, 1.30)
|
0.554
|
|
Unknown
|
0.67 (0.18, 2.54)
|
0.560
|
|
Sex, male
|
2.12 (1.55, 2.88)
|
< 0.001
|
|
Residence
| | |
|
Seoul
|
1
| |
|
Gyeonggi-do
|
2.26 (0.75, 6.86)
|
0.148
|
|
Daegu
|
2.60 (0.74, 9.16)
|
0.136
|
|
Gyeongsangbuk-do
|
2.40 (0.77, 7.49)
|
0.133
|
|
Other area
|
1.69 (0.50, 5.72)
|
0.401
|
|
Underlying disability
|
1.33 (0.94, 1.89)
|
0.109
|
|
Charlson comorbidity index, model 2
|
1.80 (1.32, 2.44)
|
< 0.001
|
|
Hypertension
|
1.36 (0.89, 2.06)
|
0.153
|
|
DM without chronic complication
|
1.87 (1.35, 2.59)
|
< 0.001
|
|
DM with chronic complication
|
1.61 (1.06, 2.45)
|
0.027
|
|
Peripheral vascular disease
|
1.19 (0.81, 1.76)
|
0.76
|
|
Renal disease
|
1.47 (0.87, 2.47)
|
0.148
|
|
Rheumatic disease
|
0.58 (0.30, 1.12)
|
0.107
|
|
Dementia
|
1.61 (1.11, 2.32)
|
0.011
|
|
Peptic ulcer disease
|
1.04 (0.73, 1.49)
|
0.818
|
|
Hemiplegia or paraplegia
|
1.92 (1.03, 3.59)
|
0.040
|
|
Moderate or severe liver disease
|
5.12 (1.32, 19.90)
|
0.018
|
|
Mild liver disease
|
0.80 (0.58, 1.10)
|
0.170
|
|
Cerebrovascular disease
|
0.57 (0.38, 0.87)
|
0.009
|
|
Congestive heart failure
|
1.91 (1.38, 2.66)
|
< 0.001
|
|
Myocardial infarction
|
0.79 (0.47, 1.33)
|
0.374
|
|
Malignancy
|
1.07 (0.78, 1.46)
|
0.694
|
|
Metastatic solid tumor
|
1.37 (0.85, 2.19)
|
0.192
|
|
AIDS/HIV
|
1.43 (0.11, 19.37)
|
0.788
|
